Return
A nanoplatform of Au nanoparticles conjugated to macrophage-derived extracellular vesicles for control of intraocular inflammation in the posterior segment
Y
F
J
F
W
D
X
Y
J
DOI:10.1016/j.nantod.2026.103124.png)
Abstract
En 中文
• M2EV@Au integrated Au nanozymes with M2 macrophage EVs to treat posterior segment intraocular inflammation. • M2EV@Au couples glucose depletion with immune reprogramming for metabolic-immunomodulatory PSII control. • A single intravitreal M2EV@Au micordose restores retinal structure and vision without steroid-induced IOP elevation.
Journal
IF:
10.9
Papers:
3.0K
Citations:
2.1W
